686
C. Walczak, T. J. Payne, C. B. Wade, M. Yonkey, M. Scheid, A. Badour, and D. K. Mohanty
Vol 52
1H-NMR (300 MHz, CDCl3): δ = 7.1 (t, J = 9.00 Hz, 1H), 6.7
(dd, J1 = 10.50 Hz, J2 = 1.50 Hz, 1H), 6.3 (d, J = 7.50 Hz, 1H),
3.3 (q, J = 6.90 Hz, 2H), 2.6 (s, 3H), 1.3 (t, J = 7.50 Hz, 3H)
ppm. 13C-NMR (75 MHz, CDCl3): δ = 148.81, 139.63, 134.31,
131.14, 124.11, 101.88, 100.53, 38.56, 15.06 ppm. IR (NaCl,
v > 1400 cmÀ1): v = 3366, 2961, 1607, 1540, 1422 cmÀ1. HRMS
m/z Calcd for C10H13N3 175.1107, found 175.1108 (TOF MS
EI), 160.0879 (100).
5-N-ethylamino-2-methyl-1H-benzimidazole (4). A three-
necked, 50 mL, round-bottomed flask containing a magnetic stir
bar and fitted with a nitrogen inlet, a thermometer and a
condenser was used as the reaction vessel. The reaction vessel
was charged with anhydrous potassium carbonate (0.65 g,
0.0046 mol). (1) (0.66 g, 0.003 mol), was weighed into a one-
dram glass vial, dissolved in NMP (5 mL) and then transferred
to the reaction vessel. The vial was subsequently washed with
12 mL of NMP, which was then added to the reaction vessel to
ensure complete transfer. The reaction mixture was stirred,
while the vessel was heated using an external temperature-
controlled oil bath. The reaction was allowed to continue at
180°C for 14 h. Upon the extraction process, (4) was found in
the aqueous layer. The aqueous layer was filtered through a
celite bed to remove all solids, and the filtrate was cooled in a
dry-ice/acetone bath and was then lyophilized for 48 hours
using a Labconco Freeze Dry System. The crude residue was
dissolved in methanol, mixed with silica gel (60–100 mesh), and
then dried to remove methanol. The desired compound, 5-
ethylamino-2-methyl-1H-benzimidazole was eluted with ethanol/
ethyl acetate (10/90 v/v) on a silica gel column. GC–MS
analysis indicated a pure product. However, in spite of repeated
attempts, we were unable to recrystallize this compound to
obtain crystals of sufficient quality for X-ray diffraction studies.
(4), Yield: 0.8 g, ~15%. mp 122–124°C. 1H-NMR (300 MHz,
CDCl3): δ = 7.3 (d, J = 8.40 Hz, 1H), 6.7 (d, J = 2.40 Hz, 1H), 6.5
(dd, J1 = 8.10 Hz, J2 = 2.40 Hz, 1H), 3.1 (q, J = 8.10 Hz 2H), 2.5
(s, 3H), 1.2 (t, J = 8.70 Hz, 3H) ppm. 13C-NMR (75 MHz,
CDCl3): δ = 150.29, 145.05, 138.76, 132.95, 116.03, 111.21,
96.05, 39.67, 15.08, 14.84 ppm. IR (NaCl, v > 1400 cmÀ1):
v = 3349, 3199, 2969, 1637, 1593, 1456, 1408 cmÀ1. HRMS m/z
Calcd for C10H13N3 175.1107, found 175.1101 (TOF MS EI),
160.0867 (100).
Acknowledgment. The work was supported by National Institute
of Health (NIH) Award Number R15HL106600 from the
National Heart, Lung and Blood Institute (NHLBI). The content
is solely the responsibility of the authors and does not represent
the official views of NHLB or NIH.
REFERENCES AND NOTES
[1] Ignarro, L. J., In Nitric Oxide Biology and Pathophysiology;
Ignarro, L. J. Ed.; Academic Press: San Diego, 2000; pp 3–19.
[2] Wang, J.; Teng, Y.; Yu, H.; Oh-Lee, J.; Mohanty, D. K.
Polymer J 2009, 41, 715.
[3] Teng, Y.; Kaminski, G. A.; Zhang, Z.; Sharma, A.; Mohanty,
D. K. Polymer 2006, 47, 4004.
[4] Yu, H.; Payne, T.; Mohanty, D. K. Chem Biol Drug Des 2011,
78, 527.
[5] Curtis, B.; Payne, T.; Ash, D. E.; Mohanty, D. K. Bioorg Med
Chem 2013, 21, 1123.
[6] (a) Pinnow, J. Chem Ber 1895, 28, 3039; (b) Nair, M. D.;
Adams, R. J Am Chem Soc 1961, 83, 3518; (c) Leitis, E.; Crosby D.,
Agric, G. J. Food Chem 1974, 22, 842; (d) Hedley, K. A.; Stanforth, S.
P. J Heterocycl Chem 1995, 32, 529; (e) McFarlane, M. D.; Smith, D.
M. Tetrahedron Lett 1987, 28, 6363; (f) Danikiewicz, W. In Adv. in Mass
Spectrometry Vol. 14; Kajalainen, E. J.; Hesso, A. E.; Jalonen, J. E.;
Karajalainen, U. P., Eds.; Elsevier: Amsterdam, 1998; pp 1.
[7] Meth-Cohn, O.; Suschitzky, H. In Adv. Heterocycl. Chem.
Vol. 14; Katritzky, A. R.; Boulton, A. J., Eds.; Academic Press: New
York, 1972; pp 211–278, and references therein.
4-N-ethylamino-2-methyl-1H-benzimidazole (5).
The
cyclization reaction was carried out similar to that of compound
(1). DMAc, instead of NMP was used as the solvent in the
presence of anhydrous potassium carbonate. The dark-red
reaction mixture was stirred, while the vessel was heated using
an external temperature-controlled oil bath. The reaction was
allowed to continue at 160°C for 24 h. During this period,
multiple aliquots were withdrawn from the reaction mixture at
increasing time intervals to monitor the progress of the reaction
using GC–MS analyses. Upon the conclusion of the reaction,
the reaction mixture turned black and opaque. The external
heating source was removed and the reaction was allowed to
cool to room temperature. The reaction mixture was diluted
with dichloromethane (30 mL) and filtered through a celite bed
to remove potassium carbonate and other residual solids. The
filtrate was distilled at reduced pressure to remove all solvents.
The crude product mixture was dissolved in a minimal amount
of dichloromethane and transferred to a separatory funnel, and
washed three times with deionized water. The organic layer was
collected, dried over magnesium sulfate, and filtered. The
filtrate was evaporated using a rotary evaporator at reduced
pressure to yield a sticky dark brown solid. 4-Ethylamino-2-
methyl-1H-benzimidazole, (5), the major component of the
mixture, was identified by GC–MS and isolated using an
alumina column with dichloromethane and ethyl acetate (70:30
v/v) as the eluent. The solution was evaporated at reduced
pressure and the blue-green solid residue was recrystallized
using dichloromethane. (5), Yield: 0.5 g, 10%. mp 63–65°C.
[8] Meth-Cohn, O. In Adv. in Heterocycl. Chem. Vol. 65;
Katritzky, A. R., Ed.; Academic Press: New York, 1996; pp 1–37, and
references therein.
[9] For recent examples of t-amino effect, see (a) Quintela, J. M.
Recent Res Devel Org Chem 2003, 7, 259; (b) Foldi, A. A.; Ludanyi,
K.; Benyei, A. C.; Matyus, P. Synlett 2010, 10, 2109; (c) Tverdokhlebov,
A. V.; Gorulya, A. P.; Tolmachev, A. A.; Kostyuk, A. N.; Chernega, A.
N.; Rusanov, E. B. Synthesis 2005, 2161; (d) Glukhareva, T. V.;
Kropotina, P. E.; Kosterina, M. F.; Nein, Y. I.; Deeva, E. V.; Morzherin,
Y. Y. Chem Heterocycl Comp 2007, 43, 76; (e) Mori, K.; Ehara, Y. K.;
Akiyama, T. Chem Lett 2009, 38, 524; (f) Pozharkskii, A. F.;
Povalykhina, M. A.; Degtyarev, A. V.; Ryabtsova, O. V.; Ozeryanskii, V.
A.; Dyablo, O. V.; Tkachuk, A. V.; Kazheva, O. N.; Cheklov, A. N.;
Dyachenko, O. A. Org Biol Chem 2011, 9, 1887; (g) Krasnov, K. A.;
Kartsev, V. G.; Khrustalev, V. N. Tetrahedron 2010, 66, 6054; (h) Rabong,
C.; Valla, C.; Kartsev, V. G.; Jordis, U. Mendeleev Commun 2007, 17, 318;
(i) Tverdokhlebov, A. V.; Gorulya, A. P.; Tolmachev, A. A.; Kostyuk, A. N.;
Chernega, A. N.; Rusanov, E. B. Tetrahedron 2006, 62, 9146.
[10] Walczak, C.; Yonkey, M.; Squattrito, P. J.; Kirschbaum, K.;
Mohanty, D. K. Acta Crystallogr 2008, C64, 248.
[11] Blackburn, B. J.; Ankrom, D. W.; Hutton, H. M. Can J Chem
1982, 60, 2987.
[12] Ewing, D. F. Org Magnetic Reson 1979, 12, 499.
[13] Stacey, G. W.; Ettling, B. V.; Papa, A. J. J Org Chem 1964,
29, 1537.
[14] Brooke, P. K.; Herbert, R. B.; Holliman, E. G. Tetrahedron
Lett 1972, 14, 761.
[15] Cadogan, J. I.; Kulik, G. S.; J Chem Soc C 1971, 2621.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet